Jillian Caldwell is a Nephrology physician affiliated with Stanford University. OpenAlex indexes 24 publications with 290 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Pasteur Dr
Stanford, CA 943052200
Telephone
650-723-4000Provider last certified this registry record 17 Apr 2024.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20231 payment
- Baxter HealthcareProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%Angiotensin receptor blocker (ARB)47.9%Losartan Potassium100%Part D≥11 patientsLoop diuretic35.2%Furosemide100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2025 per NIH RePORTER. The latest:
- Incentive Payments and Practice Patterns in Dialysis: The Case of Calcimimetics
Stanford University
FY2025$87,964F32DK141532 - Incentive Payments and Practice Patterns in Dialysis: The Case of Calcimimetics
Stanford University
FY2024$83,932F32DK141532
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- What is Medicare Advantage and Why is it the Most Important Contemporary Policy Affecting Kidney Disease?
American Journal of Kidney Diseases
2025 - Are We There Yet? Determinants of Links Between Dialysis Units and Local Transplant Programs
American Journal of Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Renumathy Dhanasekaran, MD, PhD
Stanford University
Euan Ashley, MD
Stanford University
Sarah Donaldson, MD
Stanford University
Peter Fitzgerald, MD
Stanford University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”